J&J to buy heart failure devicemaker

Johnson & Johnson plans to scoop V-Wave, a heart failure devicemaker, for up to $1.7 billion by the end of 2024. 

The acquisition will have a $600 million upfront payment and up to another $1.1 billion pending regulatory and commercial milestones, according to an Aug. 20 J&J news release. 

V-Wave is a privately held company that targets heart failure with reduced ejection fraction, and its Ventura Interatrial Shunt addressed an unmet need for about 800,000 patients, the release said. 

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like

Thank you so much for your interest in our content. Please register to access this complimentary archived content. By registering, you will receive our newsletter which can be opted out of at any time.

 

 

Already Registered? Click here to confirm.